Influenza Vaccine for Infertility
Study Summary
This trial will test whether the flu vaccine increases the chances of pregnancy for women undergoing IVF.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 985 Patients • NCT02290691Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Is the Influenza Vaccine a reliable safeguard for individuals?
"Data collected from Phase 4 trials indicates that Influenza Vaccine is safe and thus merits a score of 3."
Is it permissible for individuals over 45 to participate in this research?
"The criteria for entry into this trial necessitates that applicants are between 21 and 38 years of age. Alternatively, 14 research studies exist for individuals below the legal age limit while 36 trials encompass persons above 65."
How many participants have been enrolled in this trial thus far?
"At this moment, the trial is not enrolling patients. Initially posted on January 19th 2017 and most recently modified March 8th 2022, individuals seeking to participate in clinical studies may wish to consider the 249 trials pertaining to infertility or two active influenza vaccine tests instead."
Are there any other investigations in which the Influenza Vaccine has been utilized?
"Currently, two trials for Influenza Vaccine are in progress, neither of which have advanced to Phase 3 yet. These studies are taking place at multiple medical centres such as Bethesda, Maryland and another undisclosed location."
Are there still opportunities for enrolment into this experiment?
"This specific study, which was first announced in January 19th 2017 has ceased recruitment. Clinicaltrials.gov reveals that the last edit to this trial occurred on March 8th 2022. Fortunately, there are an additional 251 clinical trials actively searching for participants right now."
Is it possible to participate in this medical trial at the present time?
"Candidates aged 21-38 who have been diagnosed with infertility are eligible to participate in this medical trial. A total of 238 participants will be accepted into the study."